Quarterly report · Q3
2385.TEDINET S100QPPC
Period2022-07-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.6bn | 2022-07-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥9.3bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.1bn | 2021-07-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥785m | 2022-07-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥931m | 2021-07-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥785m | 2022-07-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥976m | 2021-07-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥784m | 2022-07-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥975m | 2021-07-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥496m | 2022-07-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥810m | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥641m | 2021-07-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥500m | 2022-07-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥648m | 2021-07-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥8.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥8.1bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.6bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥7.2bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.8bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.0bn | at 2022-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥18.97 | 2022-07-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.97 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.95 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.49 | 2021-07-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.62 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 80.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-03-31 | −¥1m |
| Reconciling Itemsreconciling | revenue external | 2022-07-01 → 2023-03-31 | ¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-03-31 | −¥3m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-03-31 | −¥226m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥404m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥404m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥68m |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥3.4bn |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥3.4bn |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥701m |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥1.9bn |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥1.9bn |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥115m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥382m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥380m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥3m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥43m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥463m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥463m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥83m |
| —segment total | revenue | 2022-07-01 → 2023-03-31 | ¥6.6bn |
| —segment total | revenue external | 2022-07-01 → 2023-03-31 | ¥6.6bn |
| —segment total | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥3m |
| —segment total | segment profit | 2022-07-01 → 2023-03-31 | ¥1.0bn |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2022-03-31 | −¥6m |
| Reconciling Itemsreconciling | revenue external | 2021-07-01 → 2022-03-31 | ¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2022-03-31 | −¥7m |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-03-31 | −¥231m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥336m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥336m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | segment profit | 2021-07-01 → 2022-03-31 | −¥19m |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥3.7bn |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥3.7bn |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥892m |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥2.1bn |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥2.1bn |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥124m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥474m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥467m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue intersegment | 2021-07-01 → 2022-03-31 | ¥7m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥75m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥453m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥453m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥89m |
| —segment total | revenue | 2021-07-01 → 2022-03-31 | ¥7.1bn |
| —segment total | revenue external | 2021-07-01 → 2022-03-31 | ¥7.1bn |
| —segment total | revenue intersegment | 2021-07-01 → 2022-03-31 | ¥7m |
| —segment total | segment profit | 2021-07-01 → 2022-03-31 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 315
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)あると築地有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)長井 完文 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)曽川 俊洋 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 7093544000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 6586192000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 9347879000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 975974000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 785486000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1253893000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 640593000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 496221000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 809710000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 648234000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 500220000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 817198000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 6678402000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 7216796000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 6847367000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 8056911000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 8679982000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 8489524000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 24.49 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 18.97 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 30.95 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.804 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.808 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.783 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 8.62 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 10.97 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 26158200 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 26158200 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 26158200 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 26158200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 26149700 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 261497 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 8500 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 26158200 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 261497 | |
| Cash and deposits | Prior1YearInstant | 6017253000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 5494692000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |